Latest stories on ARGX
Argenx Has Delivered 18 Consecutive Quarters of Sales Growth -- but Is the Biotech Stock Still Underrated?
Yahoo Finance67 · bullishgeneral
Argenx Has Delivered 18 Consecutive Quarters of Sales Growth -- but Is the Biotech Stock Still Underrated?
The Motley Fool67 · bullishproduct/pr
argenx to Present at Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Argenx price target raised to $1,250 from $1,230 at Morgan Stanley
The Fly61 · neutralanalyst
Argenx Buys Forte Biosciences to Bolster Autoimmune Drug Pipeline
TipRanks63 · neutralm&a
argenx Completes Acquisition of Forte Biosciences, Inc.
GlobeNewswire62 · neutralm&a
argenx Completes Acquisition of Forte Biosciences, Inc.
Business Insider62 · neutralm&a
UBS Just Upgraded Argenx Stock. Here's Why.
Barchart61 · neutralanalyst
UBS Just Upgraded Argenx Stock. Here's Why.
Yahoo Finance63 · neutralanalyst
Argenx upgraded at UBS; sees $20B peak sales in Vyvgart
Seeking Alpha68 · bullishanalyst
Why is Argen-X stock climbing today?
Investing.com Markets50 · neutralgeneral
Argenx upgraded to Buy at UBS on Vyvgart’s $20 bln sales potential
Investing.com Markets61 · neutralanalyst
Argenx price target raised to $1,415 from $1,350 at Wells Fargo
The Fly67 · bullishanalyst
Argenx Just Landed Another Phase 3 Win -- and Wall Street May Be Missing the Bigger Story
Yahoo Top73 · bullishproduct/pr
Argenx upgraded to Buy from Neutral at UBS
The Fly61 · neutralanalyst
Argenx Just Landed Another Phase 3 Win -- and Wall Street May Be Missing the Bigger Story
The Motley Fool76 · bullishproduct/pr
UBS upgrades argenx stock rating on Vyvgart sales outlook
Investing.com Analyst Ratings63 · neutralanalyst
argenx shares face Berenberg rating cut after sharp rally
Investing.com Markets38 · neutralanalyst
Argenx cut to hold at Deutsche Bank following share price run
Seeking Alpha46 · neutralanalyst
Deutsche Bank downgrades argenx stock to Hold on valuation
Investing.com Analyst Ratings47 · neutralanalyst
Argenx downgraded to Hold at Deutsche Bank after almost 50% advance
The Fly48 · neutralanalyst
Argenx downgraded to Hold from Buy at Deutsche Bank
The Fly48 · neutralanalyst
Argenx price target raised to $1,230 from $1,200 at Morgan Stanley
The Fly61 · neutralanalyst
RBC Capital raises argenx stock price target on myositis data
Investing.com Analyst Ratings63 · neutralanalyst
Argenx price target raised to $1,100 from $1,025 at RBC Capital
The Fly63 · neutralanalyst